BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23413089)

  • 1. Tuberous sclerosis complex-associated kidney angiomyolipoma: from contemplation to action.
    Pirson Y
    Nephrol Dial Transplant; 2013 Jul; 28(7):1680-5. PubMed ID: 23413089
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex.
    Wienecke R; Fackler I; Linsenmaier U; Mayer K; Licht T; Kretzler M
    Am J Kidney Dis; 2006 Sep; 48(3):e27-9. PubMed ID: 16931204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients.
    Brakemeier S; Bachmann F; Budde K
    Pediatr Nephrol; 2017 Jul; 32(7):1137-1144. PubMed ID: 27585680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular insights into tuberous sclerosis complex renal disease.
    Siroky BJ; Yin H; Bissler JJ
    Pediatr Nephrol; 2011 Jun; 26(6):839-52. PubMed ID: 21152937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Sporadic Versus Tuberous Sclerosis Complex-Associated Angiomyolipoma.
    Rabenou RA; Charles HW
    AJR Am J Roentgenol; 2015 Aug; 205(2):292-301. PubMed ID: 26204278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocal Micronodular Pneumocyte Hyperplasia in Tuberous Sclerosis Complex: Resolution with Everolimus Treatment.
    Lim KH; Silverstone EJ; Yates DH
    Am J Respir Crit Care Med; 2020 May; 201(10):e76. PubMed ID: 31870163
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptomatic unilateral renal angiomyolipoma in a child with tuberous sclerosis.
    Avolio L; Savasta S; Matteotti C; Fusillo M; Bragheri R
    Urol Int; 2001; 67(3):249-51. PubMed ID: 11598456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus and tuberous sclerosis-associated renal angiomyolipomas.
    Krischock L; Beach R; Taylor J
    Arch Dis Child; 2010 May; 95(5):391-2. PubMed ID: 20457704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition.
    Budde K; Gaedeke J
    Am J Kidney Dis; 2012 Feb; 59(2):276-83. PubMed ID: 22130643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bilateral renal angiomyolipoma associated with tuberous sclerosis: report of a case].
    Bennani S; Dahami Z; Dakir M; el Mrini M; Benjelloun S
    Ann Urol (Paris); 2000 Aug; 34(4):278-82. PubMed ID: 10994149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advance in tuberous sclerosis-related genes and their expression].
    Liu J; Piao YS; Lu DH
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):210-2. PubMed ID: 20450774
    [No Abstract]   [Full Text] [Related]  

  • 12. Everolimus in pregnancy: Case report and literature review.
    Yamamura M; Kojima T; Koyama M; Sazawa A; Yamada T; Minakami H
    J Obstet Gynaecol Res; 2017 Aug; 43(8):1350-1352. PubMed ID: 28557245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberous sclerosis complex and renal angiomyolipoma: case report and review of the literature.
    Winterkorn EB; Daouk GH; Anupindi S; Thiele EA
    Pediatr Nephrol; 2006 Aug; 21(8):1189-93. PubMed ID: 16791610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Renal Angiomyolipoma and Other Hamartomas in Patients with Tuberous Sclerosis Complex.
    Samuels JA
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1196-1202. PubMed ID: 28302901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertensive urgency and stunting. What is the diagnosis?].
    Pérez González E; Vargas de Los Monteros MT; Sánchez Moreno A
    Nefrologia; 2009; 29(4):370-1. PubMed ID: 19668318
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial.
    Cai Y; Guo H; Wang W; Li H; Sun H; Shi B; Zhang Y
    Orphanet J Rare Dis; 2018 Mar; 13(1):43. PubMed ID: 29587809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rapamycin in the treatment of renal diseases associated with tuberous sclerosis complex].
    Dun S; Zou LP; Zhang MN; Wang YY; He W; Chen HM; Hu LY; Chen XQ; Lu Q; Pang LY; Liu LY; Tang LN; Wang B
    Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):852-856. PubMed ID: 31665839
    [No Abstract]   [Full Text] [Related]  

  • 18. [HUGE RENAL ANGIOMYOLIPOMA (AML) IN TUBEROUS SCLEROSIS COMPLEX (TSC) WHICH IS CONTROLED BY EVEROLIMUS: A CASE REPORT].
    Kanbara T; Sakaeda K; Kusaka N; Akebi N
    Nihon Hinyokika Gakkai Zasshi; 2016; 107(1):54-58. PubMed ID: 28132993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of everolimus treatment for regrown renal angiomyolipoma associated with tuberous sclerosis complex after transcatheter arterial embolization.
    Hatano T; Matsu-Ura T; Mori KI; Inaba H; Endo K; Tamari M; Egawa S
    Int J Clin Oncol; 2018 Dec; 23(6):1134-1139. PubMed ID: 30069798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of mTOR inhibition in the treatment of patients with renal angiomyolipomas.
    Coombs EJ
    J Am Assoc Nurse Pract; 2013 Nov; 25(11):588-96. PubMed ID: 24170533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.